Welcome to our dedicated page for Skinhealth Systems SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SkinHealth Systems Inc. filings document the regulatory record for a Nasdaq-listed medical aesthetics company formerly known as The Beauty Health Company. The filings identify its Class A common stock, operating and financial results, non-GAAP reconciliations, and material-event disclosures tied to quarterly and annual reporting.
Its SEC record also includes proxy materials for annual stockholder voting, board and committee governance, director appointments, officer departures, compensatory arrangements, capital-structure disclosures and shareholder voting matters. These filings provide the formal disclosure framework for the company behind Hydrafacial, SkinStylus and related professional skin-health offerings.
SkinHealth Systems Inc. amended an earlier report to add details of the severance package for former Chief Revenue Officer Ronald Menezes, whose employment was terminated without cause effective May 6, 2026. The company states his departure did not involve any disagreement over financial reporting, operations, policies, or practices.
Under a Severance and General Release Agreement dated May 15, 2026, Mr. Menezes will receive total cash severance of $463,000, paid over 12 months, plus a pro-rata 2026 annual bonus payable in March 2027. He may continue health, dental, and vision coverage under COBRA with the employer portion of premiums reimbursed while severance is paid. In exchange, he provides a broad release of claims and agrees to confidentiality, non-disparagement, protection of proprietary information, return of company property, and a one-year covenant not to solicit company employees to join a competitor.
Company filing a Form 144 notice for proposed sales of Class A common stock by an affiliate. The filing lists proposed sale entries tied to restricted stock vesting with dates 11/01/2025 and 03/17/2026, showing quantities of 114,216 and 50,784 shares respectively. The intermediary listed is Fidelity Brokerage Services LLC.
SkinHealth Systems Inc. received a notice from Nasdaq that its Class A common stock no longer meets the exchange’s $1.00 minimum bid price requirement, after trading below $1.00 for 30 consecutive business days from March 26, 2026 through May 7, 2026. The stock remains listed on the Nasdaq Capital Market under the symbol SKIN, and trading is not immediately affected.
The company has 180 calendar days, until November 4, 2026, to regain compliance by having a closing bid of at least $1.00 per share for a minimum of ten consecutive business days, which Nasdaq may extend up to twenty days. If it fails to comply, SkinHealth may qualify for an additional 180-day period, potentially including a reverse stock split. If compliance is still not achieved, the stock could be delisted, although the company would have the right to appeal.
SkinHealth Systems Inc. received an updated large-holder ownership filing from Linden Capital affiliates. The reporting group states beneficial ownership of 33,360,741 Class A common shares, equal to about 25.74% of the Class A stock outstanding as of May 5, 2026, based on 129,600,040 shares reported in the company’s Form 10-Q.
LCP Edge Holdco, LLC directly holds these shares, which may be deemed beneficially owned by related Linden Capital entities and individuals Brian Miller and Anthony Davis. The amendment explains that the percentage change from prior reports results only from a change in total shares outstanding, and confirms that no transactions in the stock were made by the reporting persons in the past 60 days.
SkinHealth Systems Inc. reported mixed first quarter 2026 results with a lower full-year outlook. Net sales were $64.9 million, down (6.7)% from Q1 2025, as both delivery systems and consumables declined. Gross margin was 68.5% versus 69.8%, while adjusted gross margin held at 72.2%.
Operating expenses fell sharply to $46.2 million from $60.6 million, helping narrow net loss to $(6.6) million from $(10.1) million. Adjusted EBITDA improved to $8.5 million from $7.3 million, and the active install base grew to 36,419 systems.
The company cut its 2026 outlook, now guiding net sales of $280–$295 million and adjusted EBITDA of $35–$45 million, citing continued pressure on device sales and challenging market conditions. Cash, cash equivalents, and restricted cash were $204.4 million at March 31, 2026, down from $232.7 million at year-end 2025.
SkinHealth Systems Inc. reported that its Board of Directors terminated the employment of Chief Revenue Officer Ronald Menezes without cause, effective May 5, 2026. The company stated that his departure did not arise from any disagreement over financial reporting, operations, policies, or practices.
SkinHealth plans to negotiate a separation agreement with Menezes setting out any payments or benefits related to his termination. No material terms have been determined yet, and the company expects to file an amendment within four business days after a definitive separation agreement is executed.
Beauty Health Co/The reports that FMR LLC beneficially owned 17,183,231 shares of Class A common stock, representing 13.4% of the class as of 03/31/2026. The filing also discloses that the Fidelity Growth Company Commingled Pool held 8,073,663 shares or 6.3% of the Class A stock as of 03/31/2026. The Schedule 13G/A is signed by an authorized representative under a power of attorney dated April 13, 2026.